en · de · es · fr · pt
tirzepatide-notes.peptides3081.com › Blog › �‚¨存处理与检测方法 — Explained

�‚¨存处理与检测方法 — Explained

By Editorial Desk · published 2025-09-10 · last reviewed 2025-10-07 · Blog

A practical reference on GIP receptor: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.

This page was last updated on 2025-10-07 and is reviewed periodically as new material appears.

储存处理与检测方法

纯度评估通常综合反相色谱、体积排阻色谱与质谱三方面信息:前者反映疏水性杂质,后者反映聚集体,质谱则确认分子量与主要降解产物。有关降解途径的完整图谱——例如脱酰胺、氧化与水解各占多大比例——在不同储存条件下仍有差异,属于需要逐案验证的问题。

质量控制环节关注外观、含量、纯度、有关物质、水分与微生物限度等项目。检测结果需要有对照品和系统适用性数据支持,单次测定不足以判定批次的稳定性。实验室之间方法转移时,色谱柱品牌与梯度差异常导致保留时间漂移,因此方法验证十分必要。

固体状态的 tirzepatide 通常以冻干粉形式保存,推荐在低温、避光、干燥条件下存放,常见区间为 2 至 8 摄氏度,长期保存可考虑更低温度并避免反复冻融。冻融循环会导致肽链聚集或析出,从而影响后续定量结果。容器密封性与湿度控制同样是稳定性研究中反复强调的因素。

Analytical Characterization and Storage

Storage recommendations for tirzepatide generally specify refrigeration at 2–8 °C to maintain stability. The peptide should be protected from light and kept in its original packaging to prevent aggregation or adsorption. Freezing is not recommended because freeze-thaw cycles can cause aggregation or precipitation. Once dispensed, storage conditions and in-use periods follow product-specific labeling, which may allow room temperature storage for a limited time.

Degradation pathways for tirzepatide include deamidation, oxidation, and aggregation, which are common for therapeutic peptides. These processes can be monitored by size-exclusion chromatography (SEC) for aggregates and ion-exchange chromatography for charge variants. Forced degradation studies under acidic, basic, oxidative, and thermal stress help identify potential impurities. The exact stability profile depends on formulation, concentration, and container-closure system.

Tirzepatide at a glance

PropertyValueNotes
储存温度2 至 8 摄氏度固体粉末,避光密封
外观白色至类白色冻干粉溶解后为澄清至微乳光
溶解性易溶于水性缓冲液避免剧烈振荡
常规纯度方法反相高效液相色谱紫外或质谱检测
定量方法液相色谱串联质谱配合固相萃取前处理

Tirzepatide Pharmacology and Development History

The peptide backbone contains 39 amino acids and includes alpha-aminoisobutyric acid residues, which are not among the standard proteinogenic set. A C20 fatty diacid moiety is attached through a linker, allowing the compound to bind serum albumin and extend its circulation time. This albumin binding is the main reason the molecule supports once-weekly administration rather than more frequent dosing. The measured molecular mass is approximately 4,813 daltons, placing it firmly in the peptide rather than small-molecule class.

Tirzepatide is a synthetic peptide that activates both the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. This dual agonist profile distinguishes it from earlier incretin-based compounds that act on a single receptor. The molecule was engineered from the native GIP sequence and carries several non-natural residues that slow enzymatic breakdown. Researchers designed it to combine the insulinotropic effects of GIP signaling with the appetite and gastric-emptying effects associated with GLP-1 activation.

Development of tirzepatide took place under a research program that sought to test whether simultaneous engagement of two incretin receptors would produce greater metabolic effects than single-receptor agonism. Clinical trials were organized into the SURPASS series for type 2 diabetes and the SURMOUNT series for obesity and weight management. Regulatory clearance for type 2 diabetes came in 2022 in the United States, followed by approval for chronic weight management in 2023. The trial programs reported reductions in glycated hemoglobin and body weight relative to comparators, though long-term cardiovascular and durability data continue to accumulate.

Related pages on this site

Background and Molecular Development

The compound first appeared in the scientific literature as an investigational agent for type 2 diabetes. Clinical development proceeded through phase 1, phase 2, and phase 3 programs that measured glycemic control as a primary endpoint while recording body weight as a secondary outcome. Regulatory approval in the United States followed in 2022 for glycemic control, and a separate indication for chronic weight management was added later. Subsequent trials have examined cardiovascular outcomes in adults with elevated cardiovascular risk. Debates continue over how much of the observed effect derives from each receptor arm.

Structural work on the molecule centers on a C20 fatty diacid moiety attached through a linker to the peptide backbone. This side chain promotes reversible binding to serum albumin, which slows renal clearance and supports a prolonged action profile. The peptide backbone incorporates aminoisobutyric acid substitutions that limit recognition by digestive enzymes. Together these modifications produce a molecule that is stable enough for subcutaneous delivery but still dependent on careful manufacturing control. Analytical characterization of the active pharmaceutical ingredient typically follows the conventions used for other synthetic peptides.

Background And Receptor Pharmacology

Tirzepatide is a synthetic peptide of 39 amino acids that carries a C20 fatty diacid side chain attached through a linker. Its molecular formula is C225H348N48O68, and its molecular weight is about 4813 daltons. The compound belongs to the incretin mimetic class and is administered by subcutaneous injection. The fatty acid chain promotes binding to serum albumin, which slows renal clearance and extends the circulation time of the molecule. It was identified during screening of sequences derived from glucose-dependent insulinotropic polypeptide.

Tirzepatide activates both the glucose-dependent insulinotropic polypeptide receptor and the glucagon-like peptide-1 receptor, making it a dual agonist rather than a selective agent. Engagement of the GLP-1 receptor is linked to glucose-dependent insulin release, slower gastric emptying, and reduced appetite signalling. The relative contribution of the GIP arm remains an active research question; proposed roles include improved insulin sensitivity and altered adipose tissue handling. Receptor occupancy studies suggest the molecule interacts with both targets at circulating concentrations achieved during therapy.

Background from the literature

== Regulation == In the European Union, regulations include the species of coffee bean, geographical origin, processing detail, year of crop, solvents used in decaffeination, and caffeine level. Various institutions govern the coffee industry and help to achieve standardization and release information to the public, including the International Coffee Organization (London), Codex Alimentarius Commission of the UN (Rome), and National Coffee Association (New York).

Although used as a taxonomic category in some pre-Darwinian classifications, e.g., Linnaeus (1753), de Jussieu (1789), Lamouroux (1813), Harvey (1836), Horaninow (1843), Agassiz (1859), Wilson & Cassin (1864), in further classifications, the "algae" are seen as an artificial, polyphyletic group. Throughout the 20th century, most classifications treated the following groups as divisions or classes of algae: cyanophytes, rhodophytes, chrysophytes, xanthophytes, bacillariophytes, phaeophytes, pyrrhophytes (cryptophytes and dinophytes), euglenophytes, and chlorophytes. Later, many new groups were discovered (e.g., Bolidophyceae), and others were splintered from older groups: charophytes and glaucophytes (from chlorophytes), many heterokontophytes (e.g., synurophytes from chrysophytes, or eustigmatophytes from xanthophytes), haptophytes (from chrysophytes), and chlorarachniophytes (from xanthophytes). With the abandonment of plant-animal dichotomous classification, most groups of algae (sometimes all) were included in Protista, later also abandoned in favour of Eukaryota. However, as a legacy of the older plant life scheme, some groups that were also treated as protozoans in the past still have duplicated classifications (see ambiregnal protists).

== Bibliography == Szathmary was a prolific writer. From 1978 to 1987, he wrote a Thursday column for the Chicago Sunday Times, as well as a "Chef Louis" column for a wire service that appeared in over one hundred newspapers. He served as an editor for the 1973 edition of the 15-volume "Cookery Americana" series, in addition to writing several of his own cookbooks.

The probability that an event or difference occurred by chance alone. In clinical trials, the level of statistical significance depends on the number of participants studied and the observations made, as well as the magnitude of differences observed. (NLM) Study endpoint

Sources: en.wikipedia.org

Reference notes

In some cultural practices, particularly in the African Khoikhoi and Rwanda cultures, the labia minora are purposefully stretched by repeated pulling on them and sometimes by attaching weights. Labia stretching is a recognised, familial cultural practice in parts of Eastern and Southern Africa. This is a desired and encouraged practice by the women (starting at puberty) in order to promote better sexual satisfaction for both parties. The achieved extensions can hang down below the labia majora for up to seven inches. Children in the African diaspora practise this too, so it occurs within immigrant communities in, for example, Britain, where a BBC News report labelled it a hidden form of child abuse. The girls are subject to familial and social pressure to conform. In some cultures, including modern Western culture, women have shaved or otherwise removed the hair from part or all of the vulva. When high-cut swimsuits became fashionable, women who wished to wear them would remove the hair on either side of their pubic triangles, to avoid exhibiting pubic hair. Other women prefer to retain their vulva hair. The removal of hair from the vulva is a fairly recent phenomenon in the United States, Canada, and Western Europe, usually in the form of bikini waxing or Brazilian waxing, but has been prevalent in many Eastern European and Middle Eastern cultures for centuries, usually due to the idea that it may be more hygienic, or originating in prostitution and pornography. Hair removal may include all, most, or some of the hair.

Curd products vary by region and include cottage cheese, curd cheese (both curdled by bacteria and sometimes also rennet), farmer cheese, pot cheese, queso blanco, and paneer. The word can also refer to a non-dairy substance of similar appearance or consistency, though in these cases a modifier or the word 'curdled' is generally used. In Hungary a form of curds called túró is an ingredient in several national dishes, such as túrós palacsinta, túrós csusza and túrógombóc. In 2019, rögös túró—a form that has a unique texture "consisting of clumps of loose lumps reminiscent of cauliflower" (the name translates to "lumpy túró")—was granted the status of Traditional Speciality Guaranteed (TSG) by the EU. In Turkey, curds are called keş and are served on fried bread and are also eaten with macaroni in the provinces of Bolu and Zonguldak. In Sri Lanka, curd is eaten fresh as a dessert since antiquity. Usually buffalo curd cured in clay pots and served with kitul treacle (Caryota urens), is considered a delicacy in almost every part of the island. Although cows milk curd also is produced, Buffalo curd is the preferred variety. In Nepal, curd is produced by souring pasteurized milk with natural micro-flora. The pasteurized milk is added to a container called theki carved out of wood like Daar(Boehmeria Rugulosa). The milk is left for 12–16 hours and the micro-organisms entrapped within the Theki act as inocula. The curd produced after is used to make chhurpi and variations of it. Albanian gjiza is made by boiling whey for about 15 minutes and adding vinegar or lemon.

=== Solar cells === Selenium was used as the photoabsorbing layer in the first solid-state solar cell, which was demonstrated by the English physicist William Grylls Adams and his student Richard Evans Day in 1876. Only a few years later, Charles Fritts fabricated the first thin-film solar cell, also using selenium as the photoabsorber. As silicon solar cells emerged in the 1950s, research on selenium thin-film solar cells declined. The record efficiency of 5.0% demonstrated by Tokio Nakada and Akio Kunioka in 1985 remained unchanged for more than 30 years. In 2017, researchers from IBM achieved a new record efficiency of 6.5% by redesigning the device structure. Following this achievement, selenium has gained renewed interest as a wide bandgap photoabsorber with the potential of being integrated in tandem with lower bandgap photoabsorbers. In 2024, the first selenium-based tandem solar cell was demonstrated, showcasing a selenium top cell monolithically integrated with a silicon bottom cell. A significant deficit in the open-circuit voltage is currently the limiting factor to further improve the efficiency, necessitating defect-engineering strategies for selenium thin-films to enhance the carrier lifetime. Recent theoretical studies using first-principles defect calculations have shown that selenium exhibits intrinsic point defect tolerance, suggesting that interfaces and extended defects are the primary factors limiting device performance.

The large range and marked variability between individuals is due to variation in factors including product matrix, ignition temperature, and inhalational dynamics (e.g., number, duration, and intervals of inhalations, breath hold time, depth and volume of inhalations, size of inhaled particles, deposition site in the lungs). THC is detectable within seconds with inhalation and peak levels of THC occur after 3 to 10 minutes. Smoking or inhaling THC results in greater blood levels of THC and its metabolites and a much faster onset of action than oral administration of THC. Inhalation of THC bypasses the first-pass metabolism that occurs with oral administration. The bioavailability of THC with inhalation is increased in heavy users. Transdermal administration of THC is limited by its extreme water insolubility. Efficient skin transport can only be obtained with permeation enhancement. Transdermal administration of THC, as with inhalation, avoids the first-pass metabolism that occurs with oral administration.

=== Market size === Fine chemicals account for about 4% of the universe of chemicals. The chemical industry, valued at $2,500 billion, is dominated mainly by oil-, gas-, and mineral-derived commodities (~40%) and a large variety of specialty chemicals at the interface between industry and the public (~55%). The global production value of fine chemicals is estimated at $85 billion, of which about 2/3, or $55 billion, are produced captively, with $30 billion representing the global revenues of the fine chemical industry. The corresponding figures for the major user, the pharmaceutical industry, are $32 billion and $23 billion respectively. For a number of reasons, such as the lack of statistical data and the somewhat equivocal definition, it is not possible to exactly determine the size of the fine chemical market.

Sources: en.wikipedia.org

Reference notes

== Contraindications == Benzodiazepines require special precaution if used in the elderly, children, alcohol- or drug-dependent individuals and individuals with comorbid psychiatric disorders. Clorazepate if used late in pregnancy, the third trimester, causes a definite risk of severe benzodiazepine withdrawal syndrome in the neonate with symptoms including hypotonia, and reluctance to suck, to apnoeic spells, cyanosis, and impaired metabolic responses to cold stress. Floppy infant syndrome and sedation in the newborn may also occur. Symptoms of floppy infant syndrome and the neonatal benzodiazepine withdrawal syndrome have been reported to persist from hours to months after birth.

Efficacy was evaluated in KEYNOTE-590 (NCT03189719), a multicenter, randomized, placebo-controlled trial that enrolled 749 participants with metastatic or locally advanced esophageal or gastroesophageal junction carcinoma who were not candidates for surgical resection or definitive chemoradiation. In May 2021, the US FDA approved pembrolizumab in combination with trastuzumab, fluoropyrimidine- and platinum-containing chemotherapy for the first-line treatment of people with locally advanced unresectable or metastatic HER2 positive gastric or gastroesophageal junction (GEJ) adenocarcinoma. Approval was based on the prespecified interim analysis of the first 264 participants of the ongoing KEYNOTE-811 (NCT03615326) trial, a multicenter, randomized, double‑blind, placebo‑controlled trial in participants with HER2‑positive advanced gastric or gastroesophageal junction (GEJ) adenocarcinoma who had not previously received systemic therapy for metastatic disease. In July 2021, the US FDA approved pembrolizumab for high-risk, early-stage, triple-negative breast cancer in combination with chemotherapy as neoadjuvant treatment, and then continued as a single agent as adjuvant treatment after surgery. The FDA also granted regular approval to pembrolizumab in combination with chemotherapy for people with locally recurrent unresectable or metastatic triple-negative breast cancer whose tumors express PD-L1 (Combined Positive Score [CPS] ≥ 10) as determined by an FDA-approved test.

=== Attacks by Israel === On 25 April, the Lebanese Health Ministry reported that six people, four in Yohmor Al-Shaqeef, Nabatieh and two in Safad al-Battikh, Bint Jbeil, were killed by Israeli attacks under the orders of Israeli Prime Minister Benjamin Netanyahu to "forcefully attack Hezbollah targets" after the IDF accused the group of breaching the ceasefire agreement. On 26 April, the Lebanese Health Ministry stated that 14 people, including two women and two children, were killed and 37 others were injured by Israeli attacks in southern Lebanon. On 28 April, Israeli forces launched a double tap strike in Majdal Zoun, killing 9 people, including three emergency workers. The Israeli military stated that the strike targeted a Hezbollah commander operated in an Israeli-occupied area in southern Lebanon, despite providing no evidence. On 30 April, the National News Agency reported that several Israeli attacks targeted places in southern Lebanon, killing at least 28 people. President Joseph Aoun condemned Israel's "continuing violations", stating that "despite the ceasefire, as do demolitions of homes and places of worship, while the number of killed and wounded rises day after day". On 1 May, the Health Ministry of Lebanon reported that 13 people, including four women and a child, were killed by Israeli attacks in Habboush, Zrariyeh and Ain Baal. On 15 May, an Israeli airstrike targeted the town of Harouf, southern Lebanon, killing at least six people, including three paramedics.

Though rare, estimates of the prevalence of vaginal cuff dehiscence after hysterectomy are estimated and reported to be between 0.14 and 4.1% per the American College of Obstetricians and Gynecologists (ACOG). If the vaginal cuff is compromised, vaginal evisceration can occur with the small intestine protruding out through the vagina.

Sources: en.wikipedia.org

Frequently asked questions

固体粉末应如何存放?

建议在低温、避光、干燥环境中密封保存,常见条件为 2 至 8 摄氏度,长期存放可置于更低温度。应避免反复冻融,并尽量减少容器开启次数。

溶解后能保存多久?

溶解后的稳定时间通常短于固体形态,受浓度、缓冲液和容器材质影响。冷藏条件下一般只能维持较短时间,具体期限应通过实际稳定性实验确认。

常用哪些分析手段?

反相高效液相色谱用于纯度与含量测定,液相色谱串联质谱用于生物基质中的定量,体积排阻色谱用于检测聚集体。多种方法结合才能较完整地表征样品。

What analytical method is common for tirzepatide purity?

RP-HPLC is widely used for purity and impurity profiling. Mass spectrometry confirms identity.

Network